ANI Pharmaceuticals Community
Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
WA
Consensus Narrative from 6 Analysts
New Clinical Trials Will Expand ILUVIEN And YUTIQ Market Presence In 2025
Key Takeaways Successful Alimera acquisition integration is set to enhance financial metrics and drive notable EPS growth. Cortrophin Gel's growth, driven by new developments and market expansion, is poised to significantly boost revenue in coming years.
View narrativeUS$78.67
FV
31.5% undervalued intrinsic discount12.62%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Updated narrative